Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Louisville Metabolic and Atherosclerosis Research Center | Researchclopedia

Back to institutions

Louisville Metabolic and Atherosclerosis Research Center

Louisville, Kentuckyfacility

706

Works

84,337

Citations

160

h-index

Top Research Topics

Lipoproteins and Cardiovascular Health Diabetes, Cardiovascular Risks, and Lipoproteins Cancer, Lipids, and Metabolism

Top Researchers

Scott M. Grundy Northern Health and Social Care Trust

862 works252,934 citationsh-index: 178

Recent Research

An Assessment of Cardiovascular Health Risks in People Working from Home During the Pandemic Period: PANDEV-KALP Study

Gökhan TAZEGÜL,Volkan Aydın,et al.

20260 citations

Pharmacology and Obesity Treatment

Pharmaceutical Economics and Policy

Diet and metabolism studies

Health Systems, Economic Evaluations, Quality of Life

Diabetes Treatment and Management

Lipid metabolism and disorders

Fatty Acid Research and Health

Cholesterol and Lipid Metabolism

Adipokines, Inflammation, and Metabolic Diseases

Nicholas J. Wareham University of Essex

2,175 works247,796 citationsh-index: 233

Eric Boerwinkle Training Programs in Epidemiology and Public Health Interventions Network

1,982 works231,665 citationsh-index: 215

Kay‐Tee Khaw University of Cambridge

1,691 works156,599 citationsh-index: 190

John J.P. Kastelein QRx Pharma (United States)

1,131 works136,678 citationsh-index: 166

J. Wouter Jukema Leiden University

1,816 works126,532 citationsh-index: 164

Weekly Subcutaneous <scp>VK2735</scp> , a <scp>GIP</scp> / <scp>GLP</scp> ‐1 Receptor Dual Agonist, for Weight Management: Phase 2, Randomized, 13‐Week <scp>VENTURE</scp> Study

Harold E. Bays,Phillip D. Toth,et al.

20260 citations

New era in obesity medication access: A commentary

20251 citations

Evinacumab in patients aged 5–17 years with homozygous familial hypercholesterolemia

Robert S. Rosenson,Eliot A. Brinton,et al.

20251 citations

Zodasiran, an RNAi therapeutic targeting ANGPTL3, for treating patients with homozygous familial hypercholesterolaemia (GATEWAY): an open-label, randomised, phase 2 trial

Frederick J. Raal,Jean Bergeron,et al.

20255 citations

Icosapent ethyl reduces CVD risk in cardiovascular-kidney-metabolic syndrome: REDUCE-IT CKM

Michael Miller,Deepak L. Bhatt,et al.

20250 citations